ArticleScientific reports2021

The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems.

Nagasuryaprasad Kotikalapudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.